Goudarzipour Kourosh, Alizadeh Parinaz, Tavassol Hesameddin Hoseini, Kazemi Reyhaneh, Eshghi Peyman, Mojtahedzadeh Saeed
Pediatric Congenital Hematologic Disorders Research Center, Mofid Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.
Pediatric Cardiology Ward, Mofid Children Hospital, Shahid Beheshti University of Medical Science, Tehran, Iran.
Indian J Hematol Blood Transfus. 2017 Dec;33(4):541-544. doi: 10.1007/s12288-017-0797-9. Epub 2017 Feb 27.
One of the most common causes of mortality in major thalassemia is cardiac complications. Despite existence of several methods for diagnosis of cardiac complications in thalassemia, this sequel persists as a major problem in these patients. The aim of this study is to compare the level of serum NT-ProBNP and cardiac MRI T2* in early detection and treatment of cardiac disorders in beta thalassemia major patients. 35 major thalassemic patients on regular transfusion were selected in our center from 2013 to 2014. All of the patients were at least 8 years old. NT-ProBNP and MRIT2* analyses were carried out for these patients, and consequently the findings were compared together and analyzed. There is a strong correlation between NT-ProBNP and MRIT2* ( value < 0.001) in early detection of cardiac disorders. NT-ProBNP is an important marker for diagnosis of cardiac complications before emergence of heart failure in thalassemic patients. Given the findings of this study, it is recommended that this marker be used on a regular basis for thalassemic patients on regular transfusion.
重型地中海贫血最常见的死亡原因之一是心脏并发症。尽管存在多种诊断地中海贫血心脏并发症的方法,但这种后遗症仍是这些患者的主要问题。本研究的目的是比较血清NT-ProBNP水平和心脏MRI T2在重型β地中海贫血患者心脏疾病早期检测和治疗中的作用。2013年至2014年,我们中心选取了35例接受定期输血的重型地中海贫血患者。所有患者年龄至少8岁。对这些患者进行了NT-ProBNP和MRI T2分析,并将结果进行比较和分析。在心脏疾病的早期检测中,NT-ProBNP和MRI T2*之间存在很强的相关性(值<0.001)。NT-ProBNP是地中海贫血患者在心力衰竭出现前诊断心脏并发症的重要标志物。鉴于本研究的结果,建议对接受定期输血的地中海贫血患者定期使用该标志物。